Trigger finger. Nodular tendinous disease
Conditions
Interventions
Intervention 1: Intervention group: Ozone, 15 µg/ml, 3 cc, once, injected under sterile conditions in the A1 pulley site and under ultrasound guidance. Intervention 2: Intervention group: Methylpredni
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 75 Years
Inclusion criteria
Inclusion criteria: Patients with trigger finger and the dysfunction caused by it diagnosed by clinical examinations VAS 5 or higher Resistant to conservative treatment
Exclusion criteria
Exclusion criteria: Over 75 years of age Infectious disease or fever in recent days Any type of bone disorder, bone or joint injuries in the fingers Patients with G6PD deficiency Uncontrolled thyrotoxicosis Serious cardiovascular instability Vasovagal shock history Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: Before the intervention, 1 month after the injection and 3 months after the injection. Method of measurement: Visual Analogue Scale questionnaire.;Function Level. Timepoint: Before the intervention, 1 month after the injection and 3 months after the injection. Method of measurement: Disabilities of the Arm, Shoulder and Hand questionnaire.;Severity of the disease. Timepoint: Before the intervention, 1 month after the injection and 3 months after the injection. Method of measurement: Quinnell classification. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarsa eskandari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed